norketamine has been researched along with Refractory Depression in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bai, YM; Chen, MH; Cheng, CM; Gueorguieva, R; Hong, CJ; Krystal, JH; Li, CT; Lin, WC; Su, TP; Tu, PC | 1 |
Alonzo, A; Gálvez, V; Glue, P; Huggins, C; Li, A; Loo, CK; Martin, D; Mitchell, PB; Rodgers, A; Somogyi, AA | 1 |
Bernier, M; Moaddel, R; Singh, NS; Wainer, IW; Zarate, CA | 1 |
Brutsche, NE; Cornwell, BR; Furey, M; Grillon, C; Marquardt, CA; Salvadore, G; Zarate, CA | 1 |
3 trial(s) available for norketamine and Refractory Depression
Article | Year |
---|---|
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression.
Topics: Adult; Antidepressive Agents; Asian People; Blood Pressure; Brain-Derived Neurotrophic Factor; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Ketamine; Male; Middle Aged; Polymorphism, Genetic; Psychiatric Status Rating Scales; Taiwan; Treatment Outcome | 2017 |
Repeated intranasal ketamine for treatment-resistant depression - the way to go? Results from a pilot randomised controlled trial.
Topics: Administration, Intranasal; Administration, Intravenous; Adult; Analgesics; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Ketamine; Male; Midazolam; Middle Aged; Pilot Projects; Treatment Outcome | 2018 |
Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.
Topics: Adult; Analysis of Variance; Antidepressive Agents; Brain Mapping; Cerebral Cortex; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Electric Stimulation; Female; Fingers; Functional Laterality; Humans; Ketamine; Magnetoencephalography; Male; Middle Aged; Psychiatric Status Rating Scales; Reaction Time; Synaptic Potentials; Time Factors; Treatment Outcome | 2012 |
1 other study(ies) available for norketamine and Refractory Depression
Article | Year |
---|---|
What is hydroxynorketamine and what can it bring to neurotherapeutics?
Topics: Animals; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Rats | 2014 |